Ischemic Stroke Clinical Trials in Houston, Texas

6 studies are recruiting for ischemic stroke in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

   The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Houston Methodist Research Institute, Houston, Texas

   Locations

   31 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT04916210 on ClinicalTrials.gov

2. Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

   This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limi…

   Stage

   Phase 2

   Ages

   18 to 90

   Site

   Houston Methodist Neurological Institute, Houston, Texas

   Locations

   86 in total

   Run by

   DiaMedica Therapeutics Inc

   See if you can join NCT05065216 on ClinicalTrials.gov

3. Strategy for Improving Stroke Treatment Response

   SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Memorial Hermann Texas Medical Center, Houston, Texas

   Locations

   52 in total

   Run by

   Translational Sciences, Inc.

   See if you can join NCT05948566 on ClinicalTrials.gov

4. Personalized Transcranial Direct Current Stimulation in Stroke Recovery

   The central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomarker of plasticity.

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Houston Methodist Hospital, Houston, Texas

   Run by

   The Methodist Hospital Research Institute

   See if you can join NCT06286800 on ClinicalTrials.gov

5. StrokeNet Thrombectomy Endovascular Platform

   STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

   Stage

   Not phased

   Ages

   18 and older

   Site

   Memorial Hermann Texas Medical Center, Houston, Texas

   Locations

   41 in total

   Run by

   Medical University of South Carolina

   See if you can join NCT06289985 on ClinicalTrials.gov

6. EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment

   This is a multicenter study that will be conducted at approximately 20 centers and up to 30 centers, if the sample size will be increased following interim assessment. The Q Therapeutic System (BQ 3.0) is a wearable medical device that produces and delivers non-invasive, extremely-low-intensity and…

   Stage

   Not phased

   Ages

   22 to 80

   Site

   UTHealth Houston, Houston, Texas

   Locations

   14 in total

   Run by

   BrainQ Technologies Ltd.

   See if you can join NCT06386874 on ClinicalTrials.gov